ישראל -
עברית -
Ministry of Health
נייטשרס גייט תערובת פירות- שמפו מגן צבע
טעם טבע אלטמן בעמ - חפיפת שיער
ישראל -
עברית -
Ministry of Health
נייטשרס גייט תערובת צמחים - תחליב לחות לגוף
טעם טבע אלטמן בעמ - תחליב לחות
ישראל -
עברית -
Ministry of Health
נייטשרס גייט תערובת צמחים - מרכך לבנדר ואלו ורה
טעם טבע אלטמן בעמ - ריכוך השיער
ישראל -
עברית -
Ministry of Health
סנט טרופה- תחליב לשיזוף עצמי למראה בריא קורן וזוהר
מולטי סחר - שיזוף עצמי
ישראל -
עברית -
Ministry of Health
אוסמולייט hn
abbott medical laboratories ltd - ascorbic acid 65 mg / 100 ml; biotin 57.6 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - ready to use, high - nitrogen isotonic liquid nutrition.
ישראל -
עברית -
Ministry of Health
זולאייר 150 מג
novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.
ישראל -
עברית -
Ministry of Health
בוטומידור 10 מג מל וטרינרי
vetmarket ltd, israel - butorphanol as tartrate - תמיסה להזרקה - butorphanol as tartrate 10 mg/ml
ישראל -
עברית -
Ministry of Health
יוקריאס 50/850 מ"ג
novartis pharma services ag - metformin hydrochloride 850 mg; vildagliptin 50 mg - film coated tablets - metformin - eucreas is indicated in the treatment of type 2 diabetes mellitus:• eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.
ישראל -
עברית -
Ministry of Health
נובוגרד 1 מ"ג/500 מ"ג
novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 1 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.